Evidence map›Paper›PMID 34670882›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome.

Akira Kurishima, Mototaka Hayashi, Rin Shimozato, Ryo Isozaki, Tomoko Shioda, Akira Iijima

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Akira KurishimaDepartment of Pharmacy, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Japan.
Mototaka HayashiDepartment of Neuroendovascular Therapy, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Japan.
Rin ShimozatoDepartment of Neuroendovascular Therapy, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Japan.
Ryo IsozakiDepartment of Pharmacy, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Japan.
Tomoko ShiodaDepartment of Pharmacy, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Japan.
Akira IijimaDepartment of Neuroendovascular Therapy, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Japan.
Tokyo Yamate Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old man who was hospitalized for symptomatic epilepsy following cerebral infarction. He had a history of superior mesenteric arterial occlusion, and only 30 cm of his jejunum was intact. VPA and LEV were administered, and good blood levels were achieved at clinical doses. This suggests that the gastrointestinal tract absorption of LEV and VPA is good even in patients with short-bowel syndrome and a 30-cm jejunum.

Indexed as

EpilepsyPiracetamAgedAnticonvulsantsHumansLevetiracetamMaleValproic AcidAnticonvulsantsLevetiracetamPiracetamValproic Acidepilepsylevetiracetamshort-bowel syndromevalproic acid

Identifiers

PMID34670882
PMCPMC9152876
OpenAlexW3205744008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.